Pharmacodynamic and pharmacokinetic properties of insulin glulisine (Apidra) in comparison to insulin lispro (Humalog) in healthy lean and obese subjects
Phase of Trial: Phase I
Latest Information Update: 03 Feb 2010
At a glance
- Drugs Insulin glulisine; Insulin lispro
- Indications Diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Sanofi
- 31 Aug 2018 Biomarkers information updated
- 15 Dec 2009 Actual initiation date (Apr 2004) and actual end date (Oct 2004) added as reported by ClinicalTrials.gov.
- 12 Sep 2006 New trial record.